302 related articles for article (PubMed ID: 27890459)
21. Psychological distress is involved in CRCI in breast cancer survivors via mediating cytokine levels.
Pang L; Li W; Yao S; Jing Y; Yin X; Cheng H
Cancer Med; 2023 May; 12(10):11806-11815. PubMed ID: 36965094
[TBL] [Abstract][Full Text] [Related]
22. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
[TBL] [Abstract][Full Text] [Related]
23. Circulating levels of interleukin-17A, tumor necrosis factor-alpha, interleukin-18, interleukin-10, and cognitive performance of patients with relapsing-remitting multiple sclerosis.
Trenova AG; Slavov GS; Draganova-Filipova MN; Mateva NG; Manova MG; Miteva LD; Stanilova SA
Neurol Res; 2018 Mar; 40(3):153-159. PubMed ID: 29297273
[TBL] [Abstract][Full Text] [Related]
24. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
Quesnel C; Savard J; Ivers H
Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
[TBL] [Abstract][Full Text] [Related]
25. Changes in plasma IL-1β, TNF-α and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients.
Zhao J; Zuo H; Ding K; Zhang X; Bi Z; Cheng H
Am J Transl Res; 2020; 12(6):3046-3056. PubMed ID: 32655829
[TBL] [Abstract][Full Text] [Related]
26. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients.
Jansen CE; Cooper BA; Dodd MJ; Miaskowski CA
Support Care Cancer; 2011 Oct; 19(10):1647-56. PubMed ID: 20820813
[TBL] [Abstract][Full Text] [Related]
27. Study protocol of the Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE) trial: a two-arm, two-centre randomized controlled trial.
Brunet J; Barrett-Bernstein M; Zadravec K; Taljaard M; LeVasseur N; Srikanthan A; Bland KA; Collins B; Kam JWY; Handy TC; Hayden S; Simmons C; Smith AM; Virji-Babul N; Campbell KL
BMC Cancer; 2020 Jul; 20(1):711. PubMed ID: 32736542
[TBL] [Abstract][Full Text] [Related]
28. Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations.
Kozora E; Filley CM; Zhang L; Brown MS; Miller DE; Arciniegas DB; Pelzman JL; West SG
Lupus; 2012 Apr; 21(4):402-11. PubMed ID: 22170761
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.
Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ
J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526
[TBL] [Abstract][Full Text] [Related]
30. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
31. Telomere lengths in women treated for breast cancer show associations with chemotherapy, pain symptoms, and cognitive domain measures: a longitudinal study.
Alhareeri AA; Archer KJ; Fu H; Lyon DE; Elswick RK; Kelly DL; Starkweather AR; Elmore LW; Bokhari YA; Jackson-Cook CK
Breast Cancer Res; 2020 Dec; 22(1):137. PubMed ID: 33276807
[TBL] [Abstract][Full Text] [Related]
32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
33. Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment.
Lycke M; Pottel L; Pottel H; Ketelaars L; Stellamans K; Van Eygen K; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR
Psychooncology; 2017 May; 26(5):632-639. PubMed ID: 27338029
[TBL] [Abstract][Full Text] [Related]
34. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment.
Treanor CJ; McMenamin UC; O'Neill RF; Cardwell CR; Clarke MJ; Cantwell M; Donnelly M
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011325. PubMed ID: 27529826
[TBL] [Abstract][Full Text] [Related]
35. Cytokines are associated with longitudinal changes in cognitive performance among urban adults.
Beydoun MA; Weiss J; Obhi HK; Beydoun HA; Dore GA; Liang H; Evans MK; Zonderman AB
Brain Behav Immun; 2019 Aug; 80():474-487. PubMed ID: 30981715
[TBL] [Abstract][Full Text] [Related]
36. Changes in cytokine levels in breast cancer patients with CRCI before or after CALM intervention.
Pang L; Bi Z; Jing Y; Yin X; Zhang X; Yao S; Zhao J; Cheng H
Am J Cancer Res; 2021; 11(11):5415-5427. PubMed ID: 34873469
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
38. 'Chemobrain' in breast carcinoma?: a prologue.
Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
[TBL] [Abstract][Full Text] [Related]
39. Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning.
Cohen RA; de la Monte S; Gongvatana A; Ombao H; Gonzalez B; Devlin KN; Navia B; Tashima KT
J Neuroimmunol; 2011 Apr; 233(1-2):204-10. PubMed ID: 21146232
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
Fischer B
Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
